Clinical Trial Update: Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating angiotensin II receptor blockers, steroids, and radiotherapy in newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Angiotensin II receptor blockers (ARB)
• steroids

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Newly-diagnosed Glioblastoma | Phase 3 | Status: COMPLETED